Cataplexy

11 registered clinical trials studyying Cataplexy — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hyperso NCT05615584	University Hospital, Montpellier	N/A
Completed	A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE NCT05113745	Axsome Therapeutics, Inc.	Phase 3
Completed	A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy NCT05059223	Axsome Therapeutics, Inc.	Phase 3
Completed	An Open Label Study of FT218 in Subjects With Narcolepsy NCT04451668	Avadel	Phase 3
Unknown	Exploration of the Reward System by Functional MRI in Narco-cataplexy Patients With and Without REM Sleep Beha NCT03425214	University Hospital, Clermont-Ferrand	N/A
Completed	Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy NCT02720744	Avadel	Phase 3
Completed	Cardiovascular Variability and Heart Rate Arousal Response in Idiopathic Hypersomnia NCT02913651	Centre Hospitalier Universitaire de Saint Etienne	—
Completed	Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant) NCT01399606	Bioprojet	Phase 3
Completed	Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy NCT01067235	Bioprojet	Phase 3
Completed	Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy NCT01067222	Bioprojet	Phase 3
Completed	Provigil (Modafinil) Study by Taiwan Biotech Co. NCT00174174	National Taiwan University Hospital	N/A